NCT05027425 2024-11-22Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantUniversity of CincinnatiPhase 2 Active not recruiting30 enrolled
NCT01387503 2021-10-11Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through DownstagingFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase NA Completed74 enrolled